Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
12/27/2012 | WO2012177714A1 Substituted 6-aza-isoindolin-1-one derivatives |
12/27/2012 | WO2012177658A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
12/27/2012 | WO2012177081A2 Pharmaceutical composition for preventing and treating inflammatory disease containing an ardisia tinctoria extract or a fraction thereof as an active ingredient |
12/27/2012 | WO2012177031A1 Method for manufacturing bubbles for promoting the transfer of a functional material, and functional-material transfer device using same |
12/27/2012 | WO2012176792A1 Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases |
12/27/2012 | WO2012176131A1 Compositions and methods useful for treating pediculosis |
12/27/2012 | WO2012154122A3 A topical formulation for treatment of hyperkeratotic skin |
12/27/2012 | WO2012135597A3 Novel, protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair |
12/27/2012 | WO2012127352A3 Mia (melanoma inhibitory activity) inhibitors for detecting, preventing and curing vitiligo |
12/27/2012 | WO2012127037A3 A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative |
12/27/2012 | WO2012122082A3 Methods for activating caspase-14 expression in human skin |
12/27/2012 | WO2011159770A3 Methods and compositions for promoting hair growth |
12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
12/27/2012 | US20120329868 Paraconic acids as pigmentation activators |
12/27/2012 | US20120329863 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
12/27/2012 | US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
12/27/2012 | US20120329848 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
12/27/2012 | US20120329835 Use of 1-hydroxy-2- pyridones for the treatment of seborrheic dermatitis |
12/27/2012 | US20120329825 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts |
12/27/2012 | US20120329824 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts |
12/27/2012 | US20120329823 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts |
12/27/2012 | US20120329820 Pyridinoylpiperidines As 5-HT1F Agonists |
12/27/2012 | US20120329808 Dihydrothieno pyrimidines as akt protein kinase inhibitors |
12/27/2012 | US20120329803 Dihydropteridinones, method for production and use thereof |
12/27/2012 | US20120329782 Azepine inhibitors of janus kinases |
12/27/2012 | US20120329780 Novel kinase inhibitors |
12/27/2012 | US20120329776 Heterocyclic compounds and uses thereof |
12/27/2012 | US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments |
12/27/2012 | US20120329768 Process of forming crystals for use in a personal care composition |
12/27/2012 | US20120329754 Topical skin barrier |
12/27/2012 | US20120329737 Hybrid molecules made of lipids and lipid-analogous compounds and use thereof as pharmaceutical or cosmetic preparation |
12/27/2012 | US20120329719 Methods of use of skin wound healing compositions |
12/27/2012 | US20120329063 Novel means for the diagnosis and therapy of ctcl |
12/27/2012 | US20120328721 Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects |
12/27/2012 | US20120328720 Iridoid Based Formulations |
12/27/2012 | US20120328711 Antimicrobial system for selective, site-activated binding at target sites |
12/27/2012 | US20120328710 Selective, site-activated binding of toxins at target sites |
12/27/2012 | US20120328702 Nanoparticle compositions |
12/27/2012 | US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor |
12/27/2012 | US20120328680 Wound Treatment Therapy |
12/27/2012 | US20120328674 Non-toxic and environmentally compatible photo-protective preparations |
12/27/2012 | US20120328670 Targeted Delivery of Retinoid Compounds to the Sebaceous Glands |
12/27/2012 | US20120328661 Coumarin compounds as receptor modulators with therapeutic utility |
12/27/2012 | US20120328636 Kdr peptides and vaccines comprising the same |
12/27/2012 | US20120328635 Chaperonin 10 variants |
12/27/2012 | US20120328634 Immunoconjugates with an Intracellularly-Cleavable Linkage |
12/27/2012 | US20120328632 Inhibition of leukocyte adhesion |
12/27/2012 | US20120328617 Method for inhibiting angiogenesis |
12/27/2012 | US20120328597 Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same |
12/27/2012 | US20120328586 Methods and means for protecting the skin against pathogenic microorganisms |
12/27/2012 | US20120328581 Tissue repair |
12/27/2012 | US20120328549 Oil compositions |
12/27/2012 | US20120328544 Dermatological Treatment Methods And Formulations |
12/27/2012 | US20120328541 Anti-radical agents |
12/27/2012 | US20120328540 Cysteinyl compounds, compositions and methods of use |
12/27/2012 | US20120328539 Thickener Or Gellant For Oil Materials, Gel Composition Comprising Same, And Method Of Producing Cosmetic Material Or Topical Agent |
12/27/2012 | US20120328538 Glycerine Based Jelly Compositions |
12/27/2012 | US20120328537 Topical wound management formulation |
12/27/2012 | US20120328531 Stable liquid desoximethasone compositions with reduced oxidized impurity |
12/27/2012 | US20120328525 Nanoparticle compositions and components thereof |
12/27/2012 | US20120328519 Dentric polyglycerol sulfates and sulfonates and their use for inflammatory diseases |
12/27/2012 | CA2840875A1 Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases |
12/27/2012 | CA2840354A1 Novel formulations and methods for treating dermatological disorders or diseases |
12/27/2012 | CA2840215A1 Conjugate-based antifungal and antibacterial prodrugs |
12/26/2012 | EP2537831A1 Imidazole derivative |
12/26/2012 | EP2537512A2 Method and formulation for chemical peeling |
12/26/2012 | EP2536729A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
12/26/2012 | EP2536422A2 Methods for treating diabetic foot ulcers |
12/26/2012 | EP2536413A1 Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound |
12/26/2012 | CN202620249U Calcium ion powder capsule |
12/26/2012 | CN102844431A Diacylglycerole acyltranferase gene, and use thereof |
12/26/2012 | CN102844317A Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
12/26/2012 | CN102844027A Novel therapeutic methods for treating inflammation and immune system disorders |
12/26/2012 | CN102844026A Fungal nail treatment composition |
12/26/2012 | CN102844025A Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis |
12/26/2012 | CN102844021A Polymer/liposome nanocomposite composition for percutaneous absorption, and method for preparing same |
12/26/2012 | CN102839187A miR-29 absorption sequence, absorption carrier and uses thereof |
12/26/2012 | CN102839103A Safflower health-care wine for fall injury |
12/26/2012 | CN102838687A Extraction method for beta-glucan in oat bran |
12/26/2012 | CN102838660A Small molecule polypeptides with function of inflammation immune reaction inhibition, and applications thereof |
12/26/2012 | CN102838658A Treatment of inflammation and/or endotoxic shock |
12/26/2012 | CN102838596A Pyrrolo[2,3-b]pyridine derivative, preparation method and application thereof |
12/26/2012 | CN102838460A Series of skin-whitening (lightening) compounds |
12/26/2012 | CN102836439A Application of small interfering ribonucleic acid (siRNA) as substance for restraining formation of colloidal scar after central nervous system injury |
12/26/2012 | CN102836424A Vaccine for preventing and treating scars and preparation method thereof |
12/26/2012 | CN102836414A External Chinese medicinal oil for treating herpes zoster, burn and scald and bedsore |
12/26/2012 | CN102836413A Traditional Chinese medicine composition for treating baldness and preparation method thereof |
12/26/2012 | CN102836394A Burn and scald ointment composition and burn and scald ointment, and preparation method thereof |
12/26/2012 | CN102836383A External traditional Chinese medicine used for treating sweaty feet |
12/26/2012 | CN102836376A Traditional Chinese medicine used for treating sweaty hands and feet |
12/26/2012 | CN102836367A Bacteria-resisting, inflammation-diminishing and itching-relieving traditional Chinese medicine composition and preparation method and application thereof |
12/26/2012 | CN102836366A External liquid liniment for treating acnes |
12/26/2012 | CN102836363A Application of Pifukang solution (traditional Chinese medicine solution) to preparation of drugs for inhibiting HT-29 cell proliferation |
12/26/2012 | CN102836355A Application of puccinellia tenuiflora to preparation of drugs for treating corns and verruca vulgaris |
12/26/2012 | CN102836352A Medicament for treating hemorrhagic disease |
12/26/2012 | CN102836351A Skin care essential balm for relieving itching and diminishing swelling and preparation method thereof |
12/26/2012 | CN102836350A Traditional Chinese medicine preparations used for treating psoriasis |
12/26/2012 | CN102836341A Medicinal granule with whitening effect and preparation method thereof |
12/26/2012 | CN102836308A External Chinese medicinal preparation for treating burn and preparation method thereof |
12/26/2012 | CN102836306A Chinese medicine combination for treating horse traumatic injuries and preparation method of same |